FDA Approves the first Actemra biosimilar- called tocilizumab-bavi (Tofidence) or BIIB800 (during development). This IV FORMULATION is approved for use in active RA, polyarticular JIA and systemic JIA. https://t.co/XdQ3D2McTF https://t.co/wnusToyZTG https://t.co/w8ooCCGrI0…
Links:
FDA Approves Biogen’s TOFIDENCE™ (tocilizumab-bavi), a Biosimilar Referencing A…
https://bit.ly/3vcz48q
FDA Approves First Tocilizumab Biosimilar for US Arthritis Patients
https://bit.ly/3SaCTUZ
t.co / Twitter
https://bit.ly/48BUSbU
01-01-2024